Largest and longest studies of any FDA-approved treatment for GA
Slows GA progression with an increasing effect over time. The greatest difference was seen during the last 6 months
Proven to slow GA lesion growth
Only SYFOVRE slows GA in as few as 6 doses per year*
*Your doctor will decide how often you receive SYFOVRE (once every 25-60 days).
SYFOVRE was studied in 2 clinical studies with over 1200 people.
*After 2 years, SYFOVRE slowed GA progression by 18% and 22% (monthly, 403 patients) or by 17% and 18% (every other month, 406 patients) compared to those untreated.